Diagnosis and the Normal MRI Trap
At a Glance
Immunotherapy-induced hypophysitis can cause low pituitary hormones even when the MRI looks normal. Diagnosis depends on symptoms and blood tests such as 8 AM cortisol, ACTH, and Free T4; an early normal cosyntropin test may not exclude it.
When doctors suspect immunotherapy-induced hypophysitis (IIH), they are essentially looking for a failure of your master gland. Unlike many other conditions where a scan provides the answer, IIH is primarily diagnosed through specialized blood work and a careful review of your symptoms [1][2]. Understanding the diagnostic process can help you navigate why your doctor might be ordering specific tests at precise times.
The Preferred Initial Assessment: 8 AM Blood Tests
The most important step in evaluating your pituitary function is checking your hormone levels. Because your body’s cortisol levels naturally peak around 8 AM, doctors strongly prefer to draw your blood first thing in the morning [3][4].
- Serum Cortisol: While cutoffs vary depending on the specific laboratory assay and guidelines, an 8 AM cortisol level below 5 mcg/dL (140 nmol/L) is often a strong indicator of adrenal insufficiency [3].
- ACTH (Adrenocorticotropic Hormone): This is the signal your pituitary gland sends to your adrenal glands. In IIH, your ACTH will usually be low or “inappropriately normal” (meaning it should be high to compensate for low cortisol, but it isn’t) [5][6].
A Critical Exception: While 8 AM is preferred for diagnosis in a stable patient, if you are acutely ill with an adrenal crisis, a random cortisol test is still highly clinically important. Emergency steroid treatment must NEVER be delayed to wait for a perfect 8 AM blood draw [7].
The “Normal MRI Trap”
One of the most common pitfalls in diagnosing IIH is relying too heavily on imaging. While an MRI is an important tool to rule out other issues—such as cancer spreading to the brain (pituitary metastasis) or severe swelling pressing on the optic nerves—it frequently fails to show any inflammation in patients with IIH [8][9].
Why the MRI Often Looks Normal
- PD-1/PD-L1 Inhibitors: If you are taking drugs like Nivolumab (Opdivo) or Pembrolizumab (Keytruda), MRI abnormalities are less frequent. In these cases, the immune system often causes damage to specific cells without causing the entire gland to visibly swell [10][11].
- Timing: Even if swelling does occur (more common with CTLA-4 inhibitors like Ipilimumab), the inflammation may have already subsided by the time the scan is performed, leaving behind a gland that looks normal or even slightly shrunken [11][8].
The Bottom Line: A normal MRI does not rule out hypophysitis. If your blood tests show low hormones and you have symptoms, you still need treatment [10][1].
The Cosyntropin Stimulation Test
If your morning cortisol test is borderline, your doctor may order a cosyntropin (or Synacthen) stimulation test. During this test, you are given a synthetic version of the ACTH hormone to see if your adrenal glands respond by producing cortisol [4].
However, this test has a significant weakness early in IIH:
- Residual Adrenal Reserve: Your adrenal glands are like a battery. Even if the “charger” (the pituitary gland) breaks, the battery can stay charged and responsive for several weeks [12][13].
- False Reassurance: If your hypophysitis is very new, your adrenal glands might still be able to respond to the test, giving you a “normal” result even though your pituitary gland is failing [14][15].
Because of this, a normal stimulation test in the first few weeks of symptoms cannot be used to definitively rule out IIH. An endocrinologist will individualize the timing of any repeat testing. Do not stop taking prescribed steroids on your own to wait for a repeat test [12][16].
Evaluating Other Hormones
While cortisol is the most critical hormone to replace, the pituitary gland controls several other systems that your doctor should check:
- Thyroid Axis: To evaluate central hypothyroidism, doctors monitor Free T4 levels rather than relying solely on TSH (Thyroid Stimulating Hormone). Because the pituitary is malfunctioning, TSH levels are unreliable and cannot be used alone to adjust your medication [17][18].
- Sex Hormones: The immune attack can also lower testosterone in men or estrogen in women, which contributes to fatigue and low mood [19][20].
If an adrenal crisis is suspected, your medical team should not wait for these test results or an MRI. Life-saving steroid treatment should be started immediately based on your symptoms alone [7][21].
Common questions in this guide
Can immunotherapy-induced hypophysitis be present if my MRI is normal?
Why are cortisol and ACTH checked early in the morning?
Can a normal cosyntropin test miss hypophysitis?
Which thyroid test is most useful when hypophysitis affects the pituitary?
What should happen if an adrenal crisis is suspected?
Could recent prednisone or dexamethasone change my cortisol or ACTH results?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What were my exact 8 AM cortisol and ACTH levels, and how do they compare to the normal range?
- 2.Since my MRI was normal, what other evidence are you using to confirm my diagnosis?
- 3.If my cosyntropin stimulation test was normal, how are we managing my symptoms while we wait to see if we need a repeat test?
- 4.Are we checking my Free T4 to monitor my thyroid axis?
- 5.Do my imaging results show any swelling or pressure on the optic nerves?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (21)
- 1
Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns.
Nguyen H, Shah K, Waguespack SG, et al.
Endocrine-related cancer 2021; (28(7)):419-431.
PMID: 33890870 - 2
Hypophysitis and Secondary Adrenal Insufficiency From Immune Checkpoint Inhibitors: Diagnostic Challenges and Link With Survival.
Johnson J, Goldner W, Abdallah D, et al.
Journal of the National Comprehensive Cancer Network : JNCCN 2023; (21(3)):281-287 doi:10.6004/jnccn.2022.7098.
PMID: 36828029 - 3
Routine Screening for Central and Primary Adrenal Insufficiency during Immune-Checkpoint Inhibitor Therapy: An Endocrinology Perspective for Oncologists.
Druce I, Tawagi K, Shaw JLV, et al.
Current oncology (Toronto, Ont.) 2022; (29(7)):4665-4677 doi:10.3390/curroncol29070370.
PMID: 35877230 - 4
Adrenal Failure: An Evidence-Based Diagnostic Approach.
Shaikh S, Nagendra L, Shaikh S, Pappachan JM
Diagnostics (Basel, Switzerland) 2023; (13(10)) doi:10.3390/diagnostics13101812.
PMID: 37238296 - 5
Normal adrenocorticotropic hormone levels do not exclude adrenal insufficiency during immune checkpoint inhibitor therapy: evidence from clinical, steroid, and structural analyses.
Ishibashi Y, Baba R, Okada A, et al.
Frontiers in endocrinology 2025; (16()):1683546 doi:10.3389/fendo.2025.1683546.
PMID: 41189622 - 6
Fluctuations in plasma adrenocorticotropic hormone concentration may predict the onset of immune checkpoint inhibitor-related hypophysitis.
Bando H, Yamamoto M, Urai S, et al.
Journal for immunotherapy of cancer 2024; (12(2)) doi:10.1136/jitc-2023-008634.
PMID: 38418395 - 7
SFE/SFEDP adrenal insufficiency French consensus: Introduction and handbook.
Reznik Y, Barat P, Bertherat J, et al.
Annales d'endocrinologie 2018; (79(1)):1-22 doi:10.1016/j.ando.2017.12.001.
PMID: 29338844 - 8
MRI Findings of Immune Checkpoint Inhibitor-Induced Hypophysitis: Possible Association with Fibrosis.
Kurokawa R, Ota Y, Gonoi W, et al.
AJNR. American journal of neuroradiology 2020; (41(9)):1683-1689 doi:10.3174/ajnr.A6692.
PMID: 32763900 - 9
Pituitary metastasis of salivary gland carcinoma mimicking hypophysitis: A case report and literature review.
Tsutsui T, Hayashi K, Oda M, et al.
International journal of surgery case reports 2023; (109()):108522 doi:10.1016/j.ijscr.2023.108522.
PMID: 37524016 - 10
Immune checkpoint inhibitor-induced isolated adrenocorticotropic hormone deficiency: a systematic review.
Wang F, Shi X, Yu X, Yang Y
Frontiers in endocrinology 2024; (15()):1326684 doi:10.3389/fendo.2024.1326684.
PMID: 38318292 - 11
Immune Checkpoint Inhibitor-Related Hypophysitis and Pituitary Dysfunction: A Systematic Review of Diagnosis and Management.
SirDeshpande P, Hegde SBS, Akhtar H
Cureus 2025; (17(12)):e98717 doi:10.7759/cureus.98717.
PMID: 41510421 - 12
Acute-Onset Panhypopituitarism Nearly Missed by Initial Cosyntropin Testing.
Blum CA, Schneeberger D, Lang M, et al.
Case reports in critical care 2017; (2017()):7931438 doi:10.1155/2017/7931438.
PMID: 29109870 - 13
Central adrenal insufficiency: open issues regarding diagnosis and glucocorticoid treatment.
Ceccato F, Scaroni C
Clinical chemistry and laboratory medicine 2019; (57(8)):1125-1135.
PMID: 30427776 - 14
Central adrenal insufficiency following traumatic brain injury: a missed diagnosis in the critically injured.
Fan E, Skippen PW, Sargent MA, et al.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2017; (33(12)):2205-2207 doi:10.1007/s00381-017-3536-5.
PMID: 28721596 - 15
ACTH Stimulation Tests for the Diagnosis of Adrenal Insufficiency: Systematic Review and Meta-Analysis.
Ospina NS, Al Nofal A, Bancos I, et al.
The Journal of clinical endocrinology and metabolism 2016; (101(2)):427-34 doi:10.1210/jc.2015-1700.
PMID: 26649617 - 16
Secondary Adrenal Insufficiency: Where Is It Hidden and What Does It Look Like?
Guaraldi F, Karamouzis I, Berardelli R, et al.
Frontiers of hormone research 2016; (46()):159-70 doi:10.1159/000443915.
PMID: 27211575 - 17
Pembrolizumab-Induced Hypophysitis: A Rare Immune-Related Adverse Event in a Patient With Metastatic Non-small Cell Lung Cancer.
Al Heyasat A, Chaudhry MS, Alkharabsheh M, et al.
Cureus 2025; (17(4)):e82701 doi:10.7759/cureus.82701.
PMID: 40400852 - 18
Potential pitfalls in diagnosis of immunotherapy-induced hypothalamic-pituitary-adrenal axis abnormalities: a clinical case.
Bi Y, Adam S, Chatzimavridou V, et al.
Endocrine oncology (Bristol, England) 2022; (2(1)):K5-K9 doi:10.1530/EO-21-0023.
PMID: 37435468 - 19
Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function.
Jessel S, Weiss SA, Austin M, et al.
Frontiers in oncology 2022; (12()):836859 doi:10.3389/fonc.2022.836859.
PMID: 35350573 - 20
Central Diabetes Insipidus Following Steroid Replacement for Hypoadrenalism in Pembrolizumab-Induced Hypophysitis.
Alasmar A, San SS, Ta T, Mani SE
Cureus 2026; (18(4)):e107752 doi:10.7759/cureus.107752.
PMID: 42205670 - 21
Dexamethasone-related adrenal insufficiency in patients with brain and skull base tumours.
Benghiat H, Sanghera P, Stange D, et al.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2018; (26(12)):4031-4038 doi:10.1007/s00520-018-4264-4.
PMID: 29858690
This page is for informational purposes only and does not constitute medical advice. If you may have an adrenal crisis, seek emergency care; your endocrinology and oncology teams should interpret your tests and MRI.
Get notified when new evidence is published on Immunotherapy induced hypophysitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.